Cladophialophora carrionii can cause a disease called
chromoblastomycosis in individuals with a normal functioning immune system, unlike many other pathogenic fungi that can only cause disease in
immunocompromised individuals. It is one of the most common agents of chromoblastomycosis. The fungus changes states once it invades the animal host from the mycelial state to muriform cells that spread outward radially. This dimorphism has been suggested to increase the tolerance of
C. carrionii to extreme conditions, such as the high temperature and acidity in the human body. Muriform cells increase cell number by
septum formation within the hyphae, rather than by
budding. Chromoblastomycosis results in subcutaneous, crusty lesions that can spread over large areas on different parts of the body such as the legs, arms and face. If not treated, the lesions continue to increase in size over the body, but do not usually pose a risk of mortality. As the lesions grow, they can take on multiple forms that resemble nodes, tumours (resemble cauliflowers), and plaques. Infection causes
inflammation of the leg or foot tissue, resulting in
granulomas.
Epidemiology Chromoblastomycosis is found worldwide, most prominently in tropical and sub-tropical regions such as Mexico, Madagascar, Brazil, China, and Malaysia but some cases have been reported in the United States and Europe.
Cladophialophora carrionii causes only a minor subset of chromoblastomycosis cases, most notably in drier locations such as Madagascar, Australia and northwestern Venezuela, which are rife with plants inhabited by the fungus. Many cases of chromoblastomycosis cases target males over the age of thirty because they are predominant in the agricultural industry in rural areas, where deforestation must be carried out to provide agricultural land and they directly work with the plants that are commonly colonized by
C. carrionii.
Pathogenesis and treatment Chromoblastomycosis infection occurs by subcutaneous puncture by a thorn or splinter that is infected with
C. carrionii, such as decaying cacti and wood. Scratching at the lesions worsens the infection by spreading the fungus over larger and
distal areas of the body. Field workers who work without foot protection or clothing covering legs and arms are at greater risk for inoculation by material colonized by
C. carrionii. Immunocompromised individuals are also at risk, because the ability to produce
antibodies against fungal proteins is critical in minimizing fungal pathogenicity and
C. carrionii may penetrate deeper into muscle and bone layers if the patient is immunosuppressed. Even if an individual is
immunocompetent, they may be at risk if they carry the HLA-A29
antigen, since its presence may increase an individual's susceptibility to contracting chromoblastomycosis.
Histology tests from a skin biopsy can identify muriform cells that are commonly found in chromoblastomycosis. Identifying the specific agent that caused chromoblastomycosis can be done by
PCR assays or culturing the fungus by growing it on an agar plate and observing the colony
morphology and
sporulation characteristics. However,
C. carrionii grows quite slowly in culture, so significant results cannot be obtained until after 4–6 weeks of
incubation. During infection, the immune system of the host attempts to eliminate the fungus via engulfment and degradation by
macrophages and
neutrophils, which function in the
innate immune system. The
adaptive immune system also plays a role by activating cells such as
interleukin-6 (IL-6), the type of IL specifically produced with
C. carrionii infection, but it may have negative consequences for eradicating the fungus. It is postulated that the presence of melanin in black yeasts like
C. carrionii contributes to pathogenicity because it strengthens the fungal
cell wall and can neutralize the
enzymes produced in macrophages that normally function to break down targeted cells. Minor cases of chromoblastomycosis can be resolved by
surgery or
antifungal medications. Cold therapy (
cryosurgery) by applying cool
liquid nitrogen onto lesions can be effective if combined with antifungal therapy and
chemotherapy. More serious cases must be treated for a prolonged period of time (6 to 12 months) with the antifungals
itraconazole and
terbinafine. Antifungals have a wide range of effectiveness, curing between 15-80% of cases. However,
C. carrionii is sensitive to commonly used antifungals so cure rates are higher than seen in chromoblastomycosis infections caused by
Fonsecaea pedrosoi. Treatments less effective if the infection is chronic, resulting in high relapse rates. ==Etymology==